Erik C. Emerson - 01 Nov 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role
Chief Commercial Officer
Signature
/s/ Christine M. Farrell, Attorney-in-Fact for Erik C. Emerson
Issuer symbol
ODYY
Transactions as of
01 Nov 2022
Net transactions value
+$150,000
Form type
4
Filing time
23 Nov 2022, 15:02:53 UTC
Next filing
02 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ODYY Stock Option - Right to buy Award $31,250 +125,000 $0.2500 125,000 01 Nov 2022 Common Stock 125,000 $0.2500 Direct F1
transaction ODYY Stock Option - Right to buy Award $118,750 +475,000 $0.2500 0 01 Nov 2022 Common Stock 475,000 $0.2500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE.